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The launch of the first smartphone, followed only a few years later by tablet computers, has profoundly changed the way we communicate and interact 
with each other. This upheaval is even more remarkable as it was accompanied 
by increasingly uninterrupted internet connectivity. The new information and 
communication technologies (ICTs) are now ubiquitous in our daily lives. It is easy 
now to share and process near-immediate information, should it be objective or 
subjective, private or professional, with those around us.
The field of health care is obviously no exception. Some even perceive medicine 
as one of the areas where new ICTs are the most promising [1].  No need to 
recall that information plays a key role in medical decision making. Much of the 
medical decision is based on information collected from the patient. In addition 
to objective biomedical parameters, physicians also consider patients’ behaviors, 
risk factors, exposures, preferences, experiences, and feelings about diseases 
and treatments to make a decision. 
Patient-reported outcomes (PRO) research and tools were developed for these 
reasons. PROs are usually collected in a standardized fashion during medical 
visits, clinical trials, or observational studies. This will probably not disappear, 
notably because it is a way to guarantee the quality and reliability of results. 
But now, admittedly, this information can be supplemented and enriched by new 
ICTs. ICTs increasingly allow the quasi-continuous monitoring of the patient’s 
experience. The patient can complete a questionnaire and report on her own 
experience at home, at work, or at any other place of occupation by simply 
strumming on her mobile and connected device.
Implementing electronic PRO (ePRO) in a study could be seen as a burden as, 
compared to a paper questionnaire – the « e » typically adds studies (e.g., usability 
testing), logistics, and the costs (e.g., equipment; software development, testing 
and validation; patient and personnel training; data security). These additional 
steps and costs, however, need to be balanced against extra confidence in patient 
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compliance, data accuracy, reduced variability of measurement, regulatory 
conformance, and study efficiency [2]. Regulatory guidelines on electronic source 
data and ISPOR Task Force recommendations help recognizing the enhanced integrity 
and accuracy of ePRO data collected by electronic devices [3-4]. In addition, 
randomized clinical trials being more and more complicated including samples 
which may not be representative of the real life population, initiatives of patient-
centered websites such as www.patientslikeme.com, in collecting in a short time, 
data directly from a cohort of patients may support effective decision making [5].
Beyond efficacy data to support regulatory approval or reimbursement dossier, 
ePRO may also serve as safety endpoints [6]. The current pharmacovigilance 
reporting practice is so far from optimal that EU member states now accept direct 
consumer reports without medical confirmation. Direct information given by 
patients through electronic systems may benefit the assessment of the benefit/
risk ratio of a new drug. This is not completely new, however, and ePRO serve 
already in a number of conditions to detect safety issues and to evaluate the 
tolerability of a new therapy, e.g. the Justice Symptom checklist in HIV [7] or 
the eColumbia Suicide Severity Rating scale (eC-SSRS) [8]. ePRO not only help 
to detect serious adverse events for notification to competent authority, but 
they may also improve the management of patients enrolled in clinical trials or 
followed in clinical practice, especially in case of warning symptoms of a severe 
or fatal adverse event. The standards for developing a self-reporting of potential 
adverse events by patients (PRO-AE), however, need to be set up. For example, 
should we use standardized questionnaires that may lack the ability to capture an 
unknown side effect, or open questions with all the technological challenges of 
data processing? Also, the involvement of proxies or caregivers is needed in some 
conditions, as there are some symptoms that patients may not be aware of and 
thus not able to report adequately (e.g. cognitive dysfunction, loss of memory).
On top of the efficacy and safety endpoints, ePRO is a powerful tool to engage 
the patient, at a population and individual levels, in the drug development process 
and in the management of his/her disease. Hence, before the beginning of the 
trial, surveys can be conducted to better understand the disease burden and 
endpoints of importance for the patients. Once the drug is on the market, clinically 
relevant actions can be based on ePRO scores, e.g., to increase drug adherence, 
improve communication quality between a patient and his/her doctor or ensure 
personalized care [9].  
The step towards the “electronization” of PRO is even more remarkable as an 
increasing number of physiological and biomedical parameters can also be 
collected by intelligent applications. Blood glucose in diabetic patients, blood 
pressure in hypertensive patients, and peak flow in asthmatic patients are just a 
few of the concrete examples of medical parameters that new ICTs can empower 
the patient to follow non-invasively and quasi-continuously. Hence, the physician 
can have more than a few measures taken several weeks or months apart; 
instead, the evolution of a patient and her/his response to a given treatment can 
be appreciated quasi-continuously and can be sent to subjects themselves (e.g., 
direct feedback), to health care professionals (e.g., individual patient assessment 
or aggregated statistics of a targeted group of patients), or to the organizations 
(e.g., large-scale well-being assessments of employees). This unprecedented 
access to a large volume of real-time data coupled with the technology to analyze 
them on the fly can dramatically improve the evaluation of clinical and health 
outcome. 
To measure and improve people’s physical and psychological wellbeing, novel 
technologies have been developed, including a large-scale mobile application 
(SocialMood Labs, www.socialmoodlabs.com). The latter allows real-time 
contextual measurements to control for the numerous variables impacting 
measurement accuracy (i.e., when, where, and how the measurement is 
performed). The application presents users with a wide range of tests and 
questionnaires through the phone notification system. The application guarantees 
the randomization of the sampling throughout the day. The notifications can be 
presented even when the smartphone is not connected to the Internet. This is 
critical as behaviors, emotions, cognitions, and memories are likely to be biased 
if they are measured exclusively when users are online [10]. Tests involve various 
smartphone sensors, including the microphone, the touch screen, and the camera. 
These sensors yield rich and comprehensive assessment of patients’ health. 
Direct and personalized feedbacks can be sent to the users via their phone. This 
technology can improve health and outcome evaluation since patients themselves 
perform measurements, in their environment, and continuously throughout the 
day. Tests can be implicit or explicit to avoid biases. 
Beyond helping individuals measure and improve their well-being, such a 
technology also represents a tremendous opportunity for health care. In a large 
ongoing project, more than 70,000 subjects are currently reporting their everyday 
physical and psychological states. Using 1,000,000+ data points, the importance 
of emotions to predict people’s behavior was recently demonstrated. Indeed, the 
happiness level of individuals at time t reliably predicts the type of activities they 
choose to engage in at time t + 1 [11]. Five activities were significantly predicted by 
mood: working, resting, eating, doing sports, and leisure. This study indicates that 
mood significantly influences people’s decisions about what to do next, stressing 
the importance of emotions in shaping decision making. This project highlights 
that rich data enable the detection of important effects that are typically hidden 
in many covariates. Contextual variables can be measured and regressed out.
The technology used by SocialMood Labs captures many real-time symptoms 
involving for instance movements, cognitive abilities or stress), health behaviors 
(e.g., sleeping, eating habits, time spent exercising), and medication impact such 
as treatment efficacy, adverse events and adherence.  The control of many real-
time factors leads to a decrease in the unexplained part of the variance and to an 
increase in the statistical power of currently health-related tests and measures 
that do not use such real-life momentary assessment. Interestingly, due to the 
large sample of data collected, a level of statistical power of similar magnitude 
as the current standard assessment tools could be achieved with much fewer 
subjects, substantially reducing the cost of clinical studies. Taken together, using 
ecological momentary assessment can have a great impact on the future of health 
and well-being research, allowing for the collection of big and rich datasets that 
will improve the diagnosis, the prognosis, and ultimately, the patient outcome. 
There are, however, several regulatory, ethical, and methodological limitations/
challenges in the use of these ICTs in the field of health care. The major challenge 
of all online surveys and cohorts is making sure that a patient self-reporting 
symptoms indeed has the condition under study. Current organizations running 
patient-centered websites acknowledge that they are currently unable to tell 
whether this is the case. Paul Wicks, a leader from PatientsLikeMe, stated in a 
recent blog that “to check would be hugely time consuming and might change 
the social contract of the site, essentially saying, we don’t believe you, prove it.” 
[5] Some kind of verification will inevitably be necessary if self-reported data are 
to be used in a dossier for drug approval or HTA assessment. While self-reported 
data in these patient-centered websites are issued from real life, there may be a 
selection bias, as patients that join those sites or used mobile health applications 
may already be highly involved in their care and comfortable with sharing health 
information. These “active seekers” may not be representative of the patients as 
a whole. There is also a responsibility of empowering patients with information 
kept before by doctors. Such is the example cited by PatientsLikeMe [5]. This 
website asked patients with amyotrophic lateral sclerosis (ALS) to complete a 
questionnaire (ALS functional rating scale) commonly filled-in by physicians. 
In the past, the resulting score was not shared with the patient. This tool has 
12 questions that pertain to speech, swallowing, walking, etc., indicating the 
severity of the disease and how it would likely progress. PatientsLikeMe gave 
free access to this information for the patients themselves and provided them 
with the corresponding predictive curve of disease evolution. With only a few data 
points, it was possible to estimate if the patient has 10 years to live, 18 months, 
or less. On the one hand, that is useful information for the planning of the rest 
of patients’ lives [5]. On the other hand, delivering such sensitive information 
may be harmful and stressful for patients not willing to know. Such information 
delivery should be associated with the possibility for the patient to contact or visit 
a psychologist or a caregiver. There is also a responsibility of the owners of all 
these increasing web-based cohorts, mobile health applications, registries, and 
databases developed by many stakeholders, with all the data being shared through 
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social networking, to ensure the privacy and confidentiality of ePRO and personal 
data. Finally, ePRO databases, especially through patient-centered websites 
use algorithms, especially for establishing a diagnosis with a certain probability 
(www.symcat.com), based on patients’ self-reported information. Checking the 
adequacy and validity of these algorithms is of paramount importance. 
The growing use of mobile technologies and the Internet opens new opportunities 
to capture the patient’s voice and shape modern health care. In particular, the 
use of ICTs in health care facilitates the collection of larger volume of real-time 
and contextual measurements that enables the gathering of richer data to assess 
efficacy and/or safety of a product. In addition, ICTs facilitate the management 
of patients (enrolled in clinical trials and during clinical practice) and increase 
patients’ responsibility in their own health. More work, however, is needed to 
guarantee the integrity and confidentiality of data collected through these new 
technologies.  
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Discussion forums provide an excellent avenue to obtain guidance and insight 
beyond your community of colleagues.  The fantastic span of knowledge forums 
reach is excellent.  One discussion forum that is a must for Health Economists is 
The International Health Economics Discussion:  
https://www.jiscmail.ac.uk/cgi-bin/webadmin?A0=HEALTHECON-DISCUSS. 
The discussion forum is open to all interested in health economics.  All members 
can submit their questions as well as provide their thoughts on questions 
raised.  Past monthly discussions are also available for your review, dating 
back to September 1998.  Take a moment to log into the discussion forum and 
subscribe.  The information you were looking for may be right there and if not, 
ask away.
Do you know of any websites that you would like to share with the 
ISPoR community?  If so, contact bonnie M. Korenblat Donato, PhD, at: 
bonnie.donato@bms.com.
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